📰 Ciences News
Page 141 - Ciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ciences. Real-time updates on events, politics, business and more.
September 7, 2022
So far, DeSantis has agreed to just one debate with Crist
September 7, 2022
Urovant Sciences, Inc. receives Fortuneand Great Place to Work Best Workplaces in BioPharma (2022) recognition. Follows Urovant's Best Place to Work recognition by the Orange County Business
September 6, 2022
The award recognizes the sustainability impact of BioHarvest's Bio Plant CELLicitation technology, which enables industrial production of plant metabolites without growing the plant itself BioHarvest
September 6, 2022
POTSDAM, NY / ACCESSWIRE / September 6, 2022 / Lento Bio, Inc., a preclinical pharmaceutical company developing small-molecule therapeutics to restore ocular lens flexibility and near-vision in presbyopia
September 6, 2022
-- Approval Marks Kite's Fourth Indication in Europe for its Two Cell Therapies and First in Leukemia -- -- Overall Complete Remission of 71% and a Median Overall Survival of More Than Two Years
September 6, 2022
Regulatory News: NANOBIOTIX (Euronext: NANO -- NASDAQ: NBTX the "Company'') (Paris:NANO) (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering physics-based approaches to expand
September 6, 2022
NEW YORK and BERLIN, Sept. 07, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders
September 2, 2022
Artemis I launch more likely with NASA bugs wrangled, improved weather
September 2, 2022
CHICAGO, Sept. 2, 2022 /PRNewswire/ -- NLP in Healthcare and Life Sciences Market size to grow from USD 2.2 billion in 2022 to USD 7.2 billion by 2027, at a Compound Annual Growth Rate (CAGR)
September 1, 2022
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering